Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: J Pain Symptom Manage. 2017 Aug 30;55(2):318–333.e4. doi: 10.1016/j.jpainsymman.2017.08.020

Figure 2.

Figure 2

Symptom occurrence for each of the subgroups identified using latent class analysis for the 25 symptoms on the Memorial Symptom Assessment Scale that occurred in ≥30% of the total sample (n=1329) at Time 1 (i.e., prior to next dose of chemotherapy).